Equities

Beijing Chunlizhengda Medical Instruments Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Beijing Chunlizhengda Medical Instruments Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)14.02
  • Today's Change0.540 / 4.01%
  • Shares traded603.50k
  • 1 Year change+64.94%
  • Beta1.3180
Data delayed at least 15 minutes, as of Feb 13 2026 08:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Beijing Chunlizhengda Medical Instruments Co Ltd is a China-based company mainly engaged in the research, development, production and sales of implantable orthopedic medical devices. The Company's main products include joint prosthesis products, spinal implant products, trauma products, sports medicine products, platelet rich plasma (PRP) products, oral products and surgical robot products. Joint prosthesis products cover the four major human joints of hip, knee, shoulder, and elbow. The Company primarily distributes its products in domestic and overseas markets.

  • Revenue in CNY (TTM)1.05bn
  • Net income in CNY255.37m
  • Incorporated1998
  • Employees1.24k
  • Location
    Beijing Chunlizhengda Medical Instruments Co Ltd20F, Tower A, Gaohe Lanfeng MansionNo. 98, East Third Ring South RoadBEIJING 101100ChinaCHN
  • Phone+86 1 087361998
  • Fax+86 1 080561690
  • Websitehttp://www.clzd.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.